Clinical care of children with primary ciliary dyskinesia

References

• Lucas JS, Walker WT, Kuehni CE, et al. Primary ciliary dyskinesia (Chapter 12). In: Cordier J-F, editor. Orphan lung diseases. European Respiratory Society Monograph. Sheffield (UK): ERS Publications. Vol. 54. 2011. p. 1–19.
   Google Scholar
• Shapiro AJ, Davis SD, Ferkol T, et al. Laterality defects other than situs inversus totalis in primary ciliary dyskinesia: insights into situs ambiguus and heterotaxy. Chest. 2014;146(5):1176–1186.
   PubMed Web of Science ®Google Scholar
• Shah A, Shoemark A, MacNeill SJ, et al. A longitudinal study characterising a large adult primary ciliary dyskinesia population. Eur Respir J. 2016;48(2):441–450.
   PubMed Web of Science ®Google Scholar
• Frija-Masson J, Bassinet L, Honoré I, et al. Clinical characteristics, functional respiratory decline and follow-up in adult patients with primary ciliary dyskinesia. Thorax. 2017;72(2):154–160.
   PubMed Web of Science ®Google Scholar
• Noone PG, Leigh MW, Sannuti A, et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med. 2004;169(4):459–467.
   PubMed Web of Science ®Google Scholar
• O’Callaghan C, Chetcuti P, Moya E. High prevalence of primary ciliary dyskinesia in a British Asian population. Arch Dis Child. 2010;95(1):51–52.
   PubMed Web of Science ®Google Scholar
• Kuehni CE, Frischer T, Strippoli MP, et al. Factors influencing age at diagnosis of primary ciliary dyskinesia in European children. Eur Respir J. 2010;36(6):1248–1258.
   PubMed Web of Science ®Google Scholar
• Behan L, Dunn Galvin A, Rubbo B, et al. Diagnosing primary ciliary dyskinesia: an international patient perspective. Eur Respir J. 2016;48(4):1096–1107.
   PubMed Web of Science ®Google Scholar
• Lucas JS, Burgess A, Mitchison HM, et al. Diagnosis and management of primary ciliary dyskinesia. Arch Dis Child. 2014;99(9):850–856.
   PubMed Web of Science ®Google Scholar
• Barbato A, Frischer T, Kuehni CE, et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J. 2009;34(6):1264–1276.
   PubMed Web of Science ®Google Scholar
• Shapiro AJ, Zariwala MA, Ferkol T, et al. Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review. Pediatr Pulmonol. 2016;51(2):115–132.
   PubMed Web of Science ®Google Scholar
• Lucas JS, Barbato A, Collins SA, et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur Respir J. 2017; 49(1).
   Web of Science ®Google Scholar
• Walker WT, Young A, Bennett M, et al. Pulmonary radioaerosol mucociliary clearance in primary ciliary dyskinesia. Eur Respir J. 2014;44(2):533–535.
   PubMed Web of Science ®Google Scholar
• Marthin JK, Mortensen J, Pressler T, et al. Pulmonary radioaerosol mucociliary clearance in diagnosis of primary ciliary dyskinesia. Chest. 2007;132(3):966–976.
   PubMed Web of Science ®Google Scholar
• Anderson MP, Gregory RJ, Thompson S, et al. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science. 1991;253(5016):202–205.
   PubMed Web of Science ®Google Scholar
• Stutts MJ, Canessa CM, Olsen JC, et al. CFTR as a cAMP-dependent regulator of sodium channels. Science. 1995;269(5225):847–850.
   PubMed Web of Science ®Google Scholar
• Smith JJ, Welsh MJ. cAMP stimulates bicarbonate secretion across normal, but not cystic fibrosis airway epithelia. J Clin Invest. 1992;89(4):1148–1153.
   PubMed Web of Science ®Google Scholar
• Stoltz DA, Meyerholz DK, Welsh MJ. Origins of cystic fibrosis lung disease. N Engl J Med. 2015;372(4):351–362.
   PubMed Web of Science ®Google Scholar
• Pillarisetti N, Williamson E, Linnane B, et al. Infection, inflammation, and lung function decline in infants with cystic fibrosis. Am J Respir Crit Care Med. 2011;184(1):75–81.
   PubMed Web of Science ®Google Scholar
• Robinson M, Bye PT. Mucociliary clearance in cystic fibrosis. Pediatr Pulmonol. 2002;33(4):293–306.
   PubMed Web of Science ®Google Scholar
• Hoegger MJ, Awadalla M, Namati E, et al. Assessing mucociliary transport of single particles in vivo shows variable speed and preference for the ventral trachea in newborn pigs. Proc Nat Acad Sci USA. 2014;111(6):2355–2360.
   PubMed Web of Science ®Google Scholar
• Hoegger MJ, Fischer AJ, McMenimen JD, et al. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis. Science. 2014;345(6198):818–822.
   PubMed Web of Science ®Google Scholar
• Bush A, Payne D, Pike S, et al. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis. Chest. 2006;129(1):118–123.
   PubMed Web of Science ®Google Scholar
• Ratjen F, Waters V, Klingel M, et al. Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia. Eur Respir J. 2016;47(3):829–836.
   PubMed Web of Science ®Google Scholar
• Collins SA, Gove K, Walker W, et al. Nasal nitric oxide screening for primary ciliary dyskinesia: systematic review and meta-analysis. Eur Respir J. 2014;44(6):1589–1599.
   PubMed Web of Science ®Google Scholar
• Dell SD, Leigh MW, Lucas JS, et al. Primary ciliary dyskinesia: first health-related quality-of-life measures for pediatric patients. Ann Am Thorac Soc. 2016;13(10):1726–1735.
   PubMed Web of Science ®Google Scholar
• Schofield LM, Horobin HE. Growing up with primary ciliary dyskinesia in Bradford, UK: exploring patients experiences as a physiotherapist. Physiother Theory Pract. 2014;30(3):157–164.
   PubMed Web of Science ®Google Scholar
• Prasad SA, Main E, Dodd ME. Finding consensus on the physiotherapy management of asymptomatic infants with cystic fibrosis. Pediatr Pulmonol. 2008;43(3):236–244.
   PubMed Web of Science ®Google Scholar
• Mullowney T, Manson D, Kim R, et al. Primary ciliary dyskinesia and neonatal respiratory distress. Pediatrics. 2014;134(6):1160–1166.
   PubMed Web of Science ®Google Scholar
• Schofield LM, Duff A, Brennan C. Airway clearance techniques for primary ciliary dyskinesia; is the cystic fibrosis literature portable? Paediatr Respir Rev. 2017. [Epub ahead of print].
   PubMedGoogle Scholar
• Gokdemir Y, Karadag-Saygi E, Erdem E, et al. Comparison of conventional pulmonary rehabilitation and high-frequency chest wall oscillation in primary ciliary dyskinesia. Pediatr Pulmonol. 2014;49(6):611–616.
   PubMed Web of Science ®Google Scholar
• Jones AP, Wallis C. Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev. 2010;(3), Cd001127.
   Web of Science ®Google Scholar
• El-Abiad NM, Clifton S, Nasr SZ. Long-term use of nebulized human recombinant DNase1 in two siblings with primary ciliary dyskinesia. Resp Med. 2007;101(10):2224–2226.
   PubMed Web of Science ®Google Scholar
• ten Berge M, Brinkhorst G, Kroon AA, et al. DNase treatment in primary ciliary dyskinesia–assessment by nocturnal pulse oximetry. Pediatr Pulmonol. 1999;27(1):59–61.
   PubMed Web of Science ®Google Scholar
• O’Donnell AE, Barker AF, Ilowite JS, et al. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest. 1998;113(5):1329–1334.
   PubMed Web of Science ®Google Scholar
• Paff T, Daniels JM, Weersink EJ, et al. A randomised controlled trial on the effect of inhaled hypertonic saline on quality of life in primary ciliary dyskinesia. Eur Respir J. 2017;49(2):1601770.
   PubMed Web of Science ®Google Scholar
• Behan L, Leigh MW, Dell SD, et al. Validation of a health-related quality of life instrument for primary ciliary dyskinesia (QOL-PCD). Thorax 2017. Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• Lucas JS, Behan L, Dunn Galvin A, et al. A quality-of-life measure for adults with primary ciliary dyskinesia: QOL-PCD. Eur Respir J. 2015;46(2):375–383.
   PubMed Web of Science ®Google Scholar
• Madsen A, Green K, Buchvald F, et al. Aerobic fitness in children and young adults with primary ciliary dyskinesia. PLoS One. 2013;8(8):e71409.
   PubMed Web of Science ®Google Scholar
• Valerio G, Giallauria F, Montella S, et al. Cardiopulmonary assessment in primary ciliary dyskinesia. Eur J Clin Invest. 2012;42(6):617–622.
   PubMed Web of Science ®Google Scholar
• Phillips GE, Thomas S, Heather S, et al. Airway response of children with primary ciliary dyskinesia to exercise and beta2-agonist challenge. Eur Respir J. 1998;11(6):1389–1391.
   PubMed Web of Science ®Google Scholar
• Alanin MC, Nielsen KG, von Buchwald C, et al. A longitudinal study of lung bacterial pathogens in patients with primary ciliary dyskinesia. Clin Microbiol Infect. 2015;21(12):1093.e1091-1097.
   PubMed Web of Science ®Google Scholar
• Maglione M, Bush A, Nielsen KG, et al. Multicenter analysis of body mass index, lung function, and sputum microbiology in primary ciliary dyskinesia. Pediatr Pulmonol. 2014;49(12):1243–1250.
   PubMed Web of Science ®Google Scholar
• Rogers GB, Carroll MP, Zain NM, et al. Complexity, temporal stability, and clinical correlates of airway bacterial community composition in primary ciliary dyskinesia. J Clin Microbiol. 2013;51(12):4029–4035.
   PubMed Web of Science ®Google Scholar
• Davis SD, Ferkol TW, Rosenfeld M, et al. Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype. Am J Respir Crit Care Med. 2015;191(3):316–324.
   PubMed Web of Science ®Google Scholar
• Goddard AF, Staudinger BJ, Dowd SE, et al. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Nati Acad Sci USA. 2012;109(34):13769–13774.
   PubMed Web of Science ®Google Scholar
• Boon M, Smits A, Cuppens H, et al. Primary ciliary dyskinesia: critical evaluation of clinical symptoms and diagnosis in patients with normal and abnormal ultrastructure. Orphanet J Rare Dis. 2014;9:11.
   PubMed Web of Science ®Google Scholar
• ECFS Patient Registry: Annual Data Report 2014 [cited 2017 Jul 29]. Available from: https://www.ecfs.eu/sites/default/files/general-content-files/working-groups/ecfs-patient-registry/ECFSPR_Annual%20Report%202014_Nov2016.pdf
   Google Scholar
• Jelsbak L, Johansen HK, Frost AL, et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun. 2007;75(5):2214–2224.
   PubMed Web of Science ®Google Scholar
• Mainz JG, Naehrlich L, Schien M, et al. Concordant genotype of upper and lower airways P. aeruginosa and S. aureus isolates in cystic fibrosis. Thorax. 2009;64(6):535–540.
   PubMed Web of Science ®Google Scholar
• Bonestroo HJ, de Winter-de Groot KM, van der Ent CK, et al. Upper and lower airway cultures in children with cystic fibrosis: do not neglect the upper airways. J Cyst Fibros. 2010;9(2):130–134.
   PubMed Web of Science ®Google Scholar
• Ciofu O, Johansen HK, Aanaes K, et al. P. aeruginosa in the paranasal sinuses and transplanted lungs have similar adaptive mutations as isolates from chronically infected CF lungs. J Cyst Fibros. 2013;12(6):729–736.
   PubMed Web of Science ®Google Scholar
• Holzmann D, Speich R, Kaufmann T, et al. Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: a 10-year experience. Transplantation. 2004;77(1):134–136.
   PubMed Web of Science ®Google Scholar
• Alanin MC, Aanaes K, Hoiby N, et al. Sinus surgery can improve quality of life, lung infections, and lung function in patients with primary ciliary dyskinesia. Int Forum Allergy Rhinol. 2017;7(3):240–247.
   PubMed Web of Science ®Google Scholar
• Alanin MC, Johansen HK, Aanaes K, et al. Simultaneous sinus and lung infections in patients with primary ciliary dyskinesia. Acta Otolaryngol. 2015;135(1):58–63.
   PubMed Web of Science ®Google Scholar
• Marvig RL, Johansen HK, Molin S, et al. Genome analysis of a transmissible lineage of Pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators. PLoS Genet. 2013;9(9):e1003741.
   PubMed Web of Science ®Google Scholar
• Marvig RL, Sommer LM, Molin S, et al. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat Genet. 2015;47(1):57–64.
   PubMed Web of Science ®Google Scholar
• Sommer LM, Alanin MC, Marvig RL, et al. Bacterial evolution in PCD and CF patients follows the same mutational steps. Sci Rep. 2016;6:28732.
   PubMed Web of Science ®Google Scholar
• Johansen HK, Nørregaard L, Gøtzsche PC, et al. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?–A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection. Pediatr Pulmonol. 2004;37(5):427–432.
   PubMed Web of Science ®Google Scholar
• Saiman L, Siegel JD, LiPuma JJ, et al. Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol. 2014;35(Suppl 1):S1–s67.
   PubMed Web of Science ®Google Scholar
• Davidson AG, Chilvers MA, Lillquist YP. Effects of a Pseudomonas aeruginosa eradication policy in a cystic fibrosis clinic. Curr Opin Pulm Med. 2012;18(6):615–621.
   PubMed Web of Science ®Google Scholar
• Southern KW, Barker PM, Solis-Moya A, et al. Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev. 2012;11:Cd002203.
   PubMedGoogle Scholar
• Saiman L, Anstead M, Mayer-Hamblett N, et al. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA. 2010;303(17):1707–1715.
   PubMed Web of Science ®Google Scholar
• Altenburg J, de Graaff CS, Stienstra Y, et al. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA. 2013;309(12):1251–1259.
   PubMed Web of Science ®Google Scholar
• Wong C, Jayaram L, Karalus N, et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet. 2012;380(9842):660–667.
   PubMed Web of Science ®Google Scholar
• Kobbernagel HE, Buchvald FF, Haarman EG, et al. Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia. BMC Pulm Med. 2016;16(1):104.
   PubMed Web of Science ®Google Scholar
• Sokurenko EV, Hasty DL, Dykhuizen DE. Pathoadaptive mutations: gene loss and variation in bacterial pathogens. Trends Microbiol. 1999;7(5):191–195.
   PubMed Web of Science ®Google Scholar
• Strippoli MP, Frischer T, Barbato A, et al. Management of primary ciliary dyskinesia in European children: recommendations and clinical practice. Eur Respir J. 2012;39(6):1482–1491.
   PubMed Web of Science ®Google Scholar
• Polineni D, Davis SD, Dell SD. Treatment recommendations in primary ciliary dyskinesia. Paediatr Respir Rev. 2016;18:39–45.
   PubMed Web of Science ®Google Scholar
• Yiallouros PK, Kouis P, Middleton N, et al. Clinical features of primary ciliary dyskinesia in Cyprus with emphasis on lobectomized patients. Resp Med. 2015;109(3):347–356.
   PubMed Web of Science ®Google Scholar
• Hosie PH, Fitzgerald DA, Jaffe A, et al. Presentation of primary ciliary dyskinesia in children: 30 years’ experience. J Paediatr Child Health. 2015;51(7):722–726.
   PubMed Web of Science ®Google Scholar
• Morgan LC, Birman CS. The impact of primary ciliary dyskinesia on the upper respiratory tract. Paediatr Respir Rev. 2016;18:33–38.
   PubMed Web of Science ®Google Scholar
• Sommer JU, Schäfer K, Omran H, et al. ENT manifestations in patients with primary ciliary dyskinesia: prevalence and significance of otorhinolaryngologic co-morbidities. Eur Arch Otorhinolaryngol. 2011;268(3):383–388.
   PubMed Web of Science ®Google Scholar
• Goutaki M, Meier AB, Halbeisen FS, et al. Clinical manifestations in primary ciliary dyskinesia: systematic review and meta-analysis. Eur Respir J. 2016;48(4):1081–1095.
   PubMed Web of Science ®Google Scholar
• Pifferi M, Bush A, Caramella D, et al. Agenesis of paranasal sinuses and nasal nitric oxide in primary ciliary dyskinesia. Eur Respir J. 2011;37(3):566–571.
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1–12.
   PubMed Web of Science ®Google Scholar
• Orlandi RR, Smith TL, Marple BF, et al. Update on evidence-based reviews with recommendations in adult chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014;4(Suppl 1):S1–s15.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Cardona N, Sands P, Roberts G, et al. The acceptability and tolerability of nasal douching in children with allergic rhinitis: a systematic review. Int J Pediatr Otorhinolaryngol. 2017;98:126–135.
   PubMed Web of Science ®Google Scholar
• Beer H, Southern KW, Swift AC. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis. Cochrane Database Syst Rev. 2015;(6), Cd008253.
   PubMed Web of Science ®Google Scholar
• Mygind N, Pedersen M. Nose-, sinus- and ear-symptoms in 27 patients with primary ciliary dyskinesia. Eur J Respir Dis Suppl. 1983;127:96–101.
   PubMedGoogle Scholar
• Parsons DS, Greene BA. A treatment for primary ciliary dyskinesia: efficacy of functional endoscopic sinus surgery. Laryngoscope. 1993;103(11 Pt 1):1269–1272.
   PubMed Web of Science ®Google Scholar
• Andersen TN, Alanin MC, von Buchwald C, et al. A longitudinal evaluation of hearing and ventilation tube insertion in patients with primary ciliary dyskinesia. Int J Pediatr Otorhinolaryngol. 2016;89:164–168. .
   PubMed Web of Science ®Google Scholar
• el-Sayed Y, al-Sarhani A, al-Essa AR. Otological manifestations of primary ciliary dyskinesia. Clin Otolaryngol Allied Sci. 1997;22(3):266–270.
   PubMed Web of Science ®Google Scholar
• Leigh MW, Pittman JE, Carson JL, et al. Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome. Genet Med. 2009;11(7):473–487.
   PubMed Web of Science ®Google Scholar
• Wolter NE, Dell SD, James AL, et al. Middle ear ventilation in children with primary ciliary dyskinesia. Int J Pediatr Otorhinolaryngol. 2012;76(11):1565–1568.
   PubMed Web of Science ®Google Scholar
• Majithia A, Fong J, Hariri M, et al. Hearing outcomes in children with primary ciliary dyskinesia–a longitudinal study. Int J Pediatr Otorhinolaryngol. 2005;69(8):1061–1064.
   PubMed Web of Science ®Google Scholar
• Prulière-Escabasse V, Coste A, Chauvin P, et al. Otologic features in children with primary ciliary dyskinesia. Arch Otolaryngology–Head Neck Surg. 2010;136(11):1121–1126.
   PubMedGoogle Scholar
• Campbell R. Managing upper respiratory tract complications of primary ciliary dyskinesia in children. Curr Opin Allergy Clin Immunol. 2012;12(1):32–38.
   PubMed Web of Science ®Google Scholar
• Piatti G, De Santi MM, Torretta S, et al. Cilia and ear. Ann Otol Rhinol Laryngol. 2017;126(4):322–327.
   PubMed Web of Science ®Google Scholar
• Venekamp RP, Prasad V, Hay AD. Are topical antibiotics an alternative to oral antibiotics for children with acute otitis media and ear discharge? BMJ. 2016;352:i308.
   PubMed Web of Science ®Google Scholar
• van Dongen TM, Venekamp RP, Wensing AM, et al. Acute otorrhea in children with tympanostomy tubes: prevalence of bacteria and viruses in the post-pneumococcal conjugate vaccine era. Pediatr Infect Dis J. 2015;34(4):355–360.
   PubMed Web of Science ®Google Scholar
• Pandit C, Valentin R, De Lima J, et al. Effect of general anesthesia on pulmonary function and clinical status on children with cystic fibrosis. Paediatr Anaesth. 2014;24(2):164–169.
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343.
   PubMed Web of Science ®Google Scholar
• Maglione M, Bush A, Montella S, et al. Progression of lung disease in primary ciliary dyskinesia: is spirometry less accurate than CT? Pediatr Pulmonol. 2012;47(5):498–504.
   PubMed Web of Science ®Google Scholar
• Green K, Buchvald FF, Marthin JK, et al. Ventilation inhomogeneity in children with primary ciliary dyskinesia. Thorax. 2012;67(1):49–53.
   PubMed Web of Science ®Google Scholar
• Boon M, Vermeulen FL, Gysemans W, et al. Lung structure-function correlation in patients with primary ciliary dyskinesia. Thorax. 2015;70(4):339–345.
   PubMed Web of Science ®Google Scholar
• Irving SJ, Ives A, Davies G, et al. Lung clearance index and high-resolution computed tomography scores in primary ciliary dyskinesia. Am J Respir Crit Care Med. 2013;188(5):545–549.
   PubMed Web of Science ®Google Scholar
• Nyilas S, Schlegtendal A, Yammine S, et al. Further evidence for an association between LCI and FEV1 in patients with PCD. Thorax. 2015;70(9):896.
   PubMed Web of Science ®Google Scholar
• Gustafsson PM, De Jong PA, Tiddens HA, et al. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax. 2008;63(2):129–134.
   PubMed Web of Science ®Google Scholar
• Kraemer R, Blum A, Schibler A, et al. Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med. 2005;171(4):371–378.
   PubMed Web of Science ®Google Scholar
• Santamaria F, Montella S, Tiddens H, et al. Structural and functional lung disease in primary ciliary dyskinesia. Chest. 2008;134(2):351–357.
   PubMed Web of Science ®Google Scholar
• Cohen-Cymberknoh M, Simanovsky N, Hiller N, et al. Differences in disease expression between primary ciliary dyskinesia and cystic fibrosis with and without pancreatic insufficiency. Chest. 2014;145(4):738–744.
   PubMed Web of Science ®Google Scholar
• Brody AS, Klein JS, Molina PL, et al. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr. 2004;145(1):32–38.
   PubMed Web of Science ®Google Scholar
• Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: scoring system with thin-section CT. Radiology. 1991;179(3):783–788.
   PubMed Web of Science ®Google Scholar
• Rosenow T, Oudraad MC, Murray CP, et al. PRAGMA-CF. A quantitative structural lung disease computed tomography outcome in young children with cystic fibrosis. Am J Respir Crit Care Med. 2015;191(10):1158–1165.
   PubMed Web of Science ®Google Scholar
• Jain K, Padley SP, Goldstraw EJ, et al. Primary ciliary dyskinesia in the paediatric population: range and severity of radiological findings in a cohort of patients receiving tertiary care. Clin Radiol. 2007;62(10):986–993.
   PubMed Web of Science ®Google Scholar
• Sly PD, Brennan S, Gangell C, et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med. 2009;180(2):146–152.
   PubMed Web of Science ®Google Scholar
• Magnin ML, Cros P, Beydon N, et al. Longitudinal lung function and structural changes in children with primary ciliary dyskinesia. Pediatr Pulmonol. 2012;47(8):816–825.
   PubMed Web of Science ®Google Scholar
• Montella S, Santamaria F, Salvatore M, et al. Assessment of chest high-field magnetic resonance imaging in children and young adults with noncystic fibrosis chronic lung disease: comparison to high-resolution computed tomography and correlation with pulmonary function. Invest Radiol. 2009;44(9):532–538.
   PubMed Web of Science ®Google Scholar
• Behan L, Rubbo B, Lucas JS, et al. The patient’s experience of primary ciliary dyskinesia: a systematic review. Qual Life Res 2017. Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• Nagra A, McGinnity PM, Davis N, et al. Implementing transition: Ready Steady Go. Arch Dis Child. 2015;100(6):313–320.
   Web of Science ®Google Scholar
• Huang JS, Terrones L, Tompane T, et al. Preparing adolescents with chronic disease for transition to adult care: a technology program. Pediatrics. 2014;133(6):e1639–1646.
   PubMed Web of Science ®Google Scholar
• Implementing transition care locally and nationally using the 'Ready, Steady, Go' programme. [cited 2017 Jul 29]. Available from: www.nice.org.uk/sharedlearing/implementing-transition-care-locally-and-nationally-using-the-ready-steady-go-programme
   Google Scholar
• CLearing Lungs with ENaC inhibition in primary ciliary dyskinesia (CLEAN-PCD). [cited 2017 Jul 29]. Available from: https://clinicaltrials.gov/ct2/show/NCT02871778
   Google Scholar
• Werner C, Lablans M, Ataian M, et al. An international registry for primary ciliary dyskinesia. Eur Respir J. 2016;47(3):849–859.
   PubMed Web of Science ®Google Scholar
• Goutaki M, Maurer E, Halbeisen FS, et al. The international primary ciliary dyskinesia cohort (iPCD Cohort): methods and first results. Eur Respir J. 2017; 49(1).
   Web of Science ®Google Scholar
• Rubbo B, Behan L, Dehlink E, et al. Proceedings of the COST action BM1407 inaugural conference BEAT-PCD: translational research in primary ciliary dyskinesia - bench, bedside, and population perspectives. BMC Proc. 2016;10(9):66.
   PubMedGoogle Scholar
• BESTCILIA project. [cited 2017 Jul 29]. Available from: http://bestcilia.eu/
   Google Scholar
• BEAT-PCD project and network. [cited 2017 Jul 29]. Available from: www.beatpcd.org
   Google Scholar
• Humbert M, Wagner TO. Rare respiratory diseases are ready for primetime: from Rare Disease Day to the European Reference Networks. Eur Respir J. 2017;49(2):1700085.
   Web of Science ®Google Scholar
• Lai M, Pifferi M, Bush A, et al. Gene editing of DNAH11 restores normal cilia motility in primary ciliary dyskinesia. J Med Genet. 2016;53(4):242–249.
   PubMed Web of Science ®Google Scholar